Medicine and Dentistry
25 Hydroxyvitamin D
5%
Aortic Valve
5%
Apoplexy
13%
Atherosclerosis
100%
Atrial Fibrillation
9%
Biological Marker
8%
Body Mass Index
6%
Cardiology
9%
Cardiovascular Disease
77%
Cardiovascular Disease Prevention
11%
Cardiovascular Disease Risk Factor
10%
Cardiovascular Risk
16%
Cardiovascular System
42%
Chronic Kidney Disease
5%
Chronic Obstructive Pulmonary Disease
6%
Clinical Trial
5%
Clinician
7%
Cohort Analysis
6%
Computer Assisted Tomography
6%
Coronary Artery
21%
Coronary Artery Disease
5%
COVID-19
11%
Diabetes
15%
Disease
11%
Drug Therapy
6%
Dyslipidemia
5%
Ejection Fraction
5%
Hazard Ratio
13%
Heart Failure
25%
Hormone Determination
7%
Ischemic Heart Disease
14%
Isotopes of Calcium
33%
Low Density Lipoprotein Cholesterol
9%
Meta-Analysis
8%
Myocardial Infarction
7%
Odds Ratio
8%
Physical Activity
9%
Postmenopause
10%
Prevalence
17%
Preventive Cardiology
6%
Primary Prevention
13%
Proportional Hazards Model
5%
Randomized Controlled Trial
5%
Resting Heart Rate
5%
Sex Difference
11%
Sex Hormone
12%
Statin
14%
Supplementation
8%
Systematic Review
6%
Vitamin D
21%
Keyphrases
25-hydroxyvitamin D (25OHD)
19%
Acute Myocardial Infarction
6%
Atherosclerotic Cardiovascular Disease (ASCVD)
23%
Atherosclerotic Cardiovascular Disease Risk
8%
Atherosclerotic Risk Factors
22%
Atrial Fibrillation
9%
Body Mass Index
7%
Cardiovascular Disease
34%
Cardiovascular Disease Events
8%
Cardiovascular Health
15%
Cardiovascular Mortality
10%
Cardiovascular Outcomes
10%
Cardiovascular Prevention
14%
Cardiovascular Risk
35%
Confidence Interval
25%
Coronary Artery Calcium
16%
Coronary Artery Disease
10%
COVID-19
7%
Diabetes
8%
Hazard Ratio
12%
Heart Failure
15%
Heart Failure with Preserved Ejection Fraction (HFpEF)
6%
High Risk
10%
Hospitalization
8%
Hypertension
9%
Ideal Cardiovascular Health
7%
Incident Heart Failure
11%
Intact Parathyroid Hormone (iPTH)
8%
Low-density Lipoprotein Cholesterol (LDL-C)
12%
Meta-analysis
9%
Multi-Ethnic Study of Atherosclerosis
74%
Myocardial Infarction
7%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
6%
Odds Ratio
6%
Older Adults
11%
Physical Activity
8%
Postmenopausal Women
9%
Primary Prevention
10%
Race-ethnicity
8%
Risk Factors
7%
Serum 25-hydroxyvitamin D
6%
Sex Differences
8%
Sex Hormones
6%
Statins
8%
Systematic Meta-analysis
9%
United States
21%
Vitamin D
13%
Vitamin D Status
8%
Vitamin D Supplementation
8%
White People
6%